Shares of AbbVie (NYSE: ABBV) soared 21% in 2020, the stock’s best performance since 2017. The big pharma hasn’t gotten off to a great start so far in 2021, though, with shares down year to date.
The beginning of a bounce could be underway now, however, for the Dividend Aristocrat. AbbVie announced positive fourth-quarter results before the market opened on Wednesday. Here are the highlights from the company’s update.